Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Neprinol is a proprietary dietary supplement formulated as a blend of systemic and proteolytic enzymes, including serrapeptase, nattokinase, bromelain, papain, lipase, protease, rutin, and amla. Its primary aim is to support healthy fibrin levels in the body by promoting the breakdown of excess fibrin and unwanted proteins in the bloodstream. This action may help maintain normal blood viscosity and circulation while supporting joint health and immune function. The enzymes in Neprinol are thought to facilitate tissue repair by aiding in the removal of inflammatory factors and protein debris from blood vessels. The product is marketed for its potential benefits on cardiovascular health (by supporting proper blood flow), joint comfort (by modulating inflammation), immune system support (through clearing irritants), digestive health (via enhanced nutrient absorption), and overall well-being[1][2][4][5][7]. The mechanism centers on enzymatic degradation of fibrin—a key component in clot formation—thus potentially reducing abnormal clotting risk or excessive inflammation[5]. Key ingredients include: - **Serrapeptase:** A proteolytic enzyme with anti-inflammatory properties. - **Nattokinase:** A potent fibrinolytic enzyme that helps break down clots. - **Bromelain & Papain:** Enzymes that aid digestion and modulate inflammation. - **Lipase & Protease:** Support fat/protein digestion; may assist systemic effects. Neprinol is not an FDA-approved pharmaceutical drug but rather a dietary supplement intended for general wellness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Neprinol.